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Abstract 24	
Fat and carbohydrate are the major fuel sources utilised for oxidative, mitochondrial 25	
adenosine triphosphate (ATP) resynthesis during human skeletal muscle contraction. 26	
The relative contribution of these two substrates to ATP resynthesis and total energy 27	
expenditure during exercise can vary substantially, and is predominantly determined 28	
by fuel availability and exercise intensity and duration. For example, the increased 29	
ATP demand that occurs with an increase in exercise intensity is met by increases in 30	
both fat and carbohydrate oxidation up to an intensity of around 60 to 70% of 31	
maximal oxygen consumption (VO2max). When exercise intensity increases beyond 32	
this workload skeletal muscle carbohydrate utilisation is accelerated, which results in 33	
a reduction and inhibition of the relative and absolute contribution of fat oxidation to 34	
total energy expenditure. However, the precise mechanisms regulating muscle fuel 35	
selection and underpinning the decline in fat oxidation remain unclear. This brief 36	
review will primarily address the theory that a carbohydrate flux mediated reduction 37	
in the availability of muscle carnitine to the mitochondrial enzyme carnitine 38	
palmitoyltransferase 1 (CPT1), a rate limiting step in mitochondrial fat translocation, 39	
is a key mechanism for the decline in fat oxidation during high intensity exercise. 40	
This is discussed in relation to recent work in this area investigating fuel metabolism 41	
at various exercise intensities and taking advantage of the discovery that skeletal 42	
muscle carnitine content can be nutritionally increased in vivo in humans. 43	
  44	
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Introduction 45	
Carbohydrate and fat are the primary fuel sources for mitochondrial ATP resynthesis 46	
in human skeletal muscle. The relative utilisation of these two substrates during 47	
exercise can vary substantially and depends strongly on substrate availability and 48	
exercise duration and intensity. Fat constitutes the largest energy reserve in the body 49	
and in terms of the amount available it is not limiting to endurance exercise 50	
performance. However, fat exhibits a relatively low maximal rate of oxidation in vivo, 51	
which begins to measurably decline at an exercise intensity of around 60 to 70% of 52	
maximal oxygen consumption (VO2max), above which muscle glycogen becomes the 53	
major fuel supporting ATP resynthesis(1,2,3). The muscle glycogen stores are limited 54	
and it has been well established that muscle glycogen depletion coincides with fatigue 55	
during very prolonged high intensity endurance exercise(4). As fatigue can be 56	
postponed by increasing pre-exercise muscle glycogen content(4), it is thought that 57	
augmenting the rate of fat oxidation during endurance exercise could delay glycogen 58	
depletion and improve prolonged endurance exercise performance. Indeed, it has long 59	
been known that enhanced fat oxidation is one of the main muscle adaptations to 60	
endurance exercise training(5). However, the mechanisms that regulate the relative 61	
contributions of carbohydrate and fat oxidation in skeletal muscle during exercise 62	
have not been clearly elucidated. Several potential regulatory points (Figure 1) could 63	
influence the decline in the rate of fat oxidation in skeletal muscle during high 64	
intensity endurance exercise, including: 1) regulation of lipolysis within adipose 65	
tissue and intramuscular triacylglycerol (IMTG) pools; 2) transport and delivery of 66	
circulating free fatty acids from adipose tissue stores to working skeletal muscle; 3) 67	
transport of fatty acids across the muscle cell membrane and within the cell cytosol to 68	
the outer mitochondrial membrane; 4) transport of fatty acid across the outer 69	
mitochondrial membrane via carnitine palmitoyltransferase 1 (CPT1), the rate 70	
limiting step in fatty acid oxidation, and 5) intramitochondrial enzymatic reactions 71	
distal to CPT1. The present review will primarily address the theory that a 72	
carbohydrate flux mediated reduction in the availability of muscle carnitine, the major 73	
substrate for CPT1, is a key mechanism for the decline in fat oxidation during high 74	
intensity exercise. This is discussed in relation to recent work in this area taking 75	
advantage of the discovery that skeletal muscle carnitine content can be nutritionally 76	
increased in vivo in humans and have a significant impact upon fuel selection during 77	
endurance exercise. 78	
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 79	
Insert Figure 1 80	
 81	
Integration of fat and carbohydrate oxidation during exercise 82	
There is increasing evidence to suggest that fat oxidation during exercise is directly 83	
regulated by the rate of flux though the mitochondrial pyruvate dehydrogenase 84	
enzyme complex (PDC), a rate limiting step in skeletal muscle carbohydrate 85	
oxidation. Increasing exercise intensity, from moderate to high, or increasing 86	
carbohydrate availability during exercise, increases glycolysis and flux through the 87	
PDC with a corresponding decrease in the rate of fat oxidation(1,2,6). A likely site of 88	
the regulation of fat oxidation by carbohydrate flux is CPT1. Increasing glucose 89	
availability at rest, via a hyperglycaemic-hyperinsulinaemic clamp, decreases long-90	
chain fatty acid ([13C]oleate) oxidation with no effect on medium-chain fatty acid 91	
([13C]octanoate) oxidation(7). This would suggest an inhibition of fat oxidation at the 92	
level of CPT1 as medium-chain fatty acids cross the mitochondrial membrane to be 93	
oxidized independently of CPT1. The same effect of carbohydrate was seen during 94	
moderate intensity exercise at 50% VO2max, where hyperglycaemia (induced as a 95	
result of pre-exercise ingestion of glucose) increased glycolytic flux and reduced 96	
long-chain fatty acid ([1-13C]palmitate) oxidation(8). Again, medium-chain [1-97	
13C]octanoate oxidation was unaffected, suggesting that carbohydrate metabolism can 98	
also directly limit fat oxidation at the level of CPT1 during exercise. It should be 99	
noted that these responses might have been mediated, at least in part, via an insulin-100	
induced inhibition of adipose tissue lipolysis, resulting in decreased plasma free fatty 101	
acid (FFA) availability. However, in the study of Sidossis and Wolfe(7), normal 102	
plasma FFA was maintained constant and muscle long-chain acyl-CoA levels did not 103	
change, suggesting FFA availability, uptake, and cytosolic transport was not limiting. 104	
Furthermore, restoring plasma FFA concentration during the exercise trial, via lipid 105	
and heparin infusion, did not fully restore fat oxidation rates, again suggesting that the 106	
inhibitory effect of increased carbohydrate availability resides at the level of 107	
oxidation, rather than FFA availability(9). In support of this theory, increasing fat 108	
oxidation rates 2-fold during exercise at 65% VO2peak, due to different pre-exercise 109	
muscle glycogen content, has no effect on muscle FFA uptake rates or FAT/CD36 110	
(the protein responsible for FFA uptake into skeletal muscle) protein levels(6).  111	
 112	
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A glance at CPT1 regulation during exercise 113	
Several intracellular mechanisms leading to the down regulation of long-chain fatty 114	
acid oxidation at the level of CPT1 during exercise with high glycolytic flux have 115	
been proposed, including inhibition of CPT1 by malonyl-CoA, acylcarnitine, or 116	
acidosis, and reduced substrate availability of carnitine or long-chain fatty acyl-CoA. 117	
The following section will focus on mechanisms that have been investigated in vivo 118	
and in humans.  119	
 120	
Malonyl-CoA is a potent inhibitor of CPT1 activity in vitro and is a likely candidate 121	
as the intracellular regulator of the rate of long-chain fatty acid oxidation human 122	
skeletal muscle. Indeed, in resting human skeletal muscle, changes in malonyl-CoA 123	
concentration have occurred with opposite changes in fat oxidation(10, 11). Skeletal 124	
muscle malonyl-CoA concentration is regulated by AMP-activated protein kinase 125	
(AMPK) and by the cytosolic concentration of citrate, which inactivate and activate 126	
the enzyme responsible for malonyl-CoA synthesis from acetyl-CoA (acetyl-CoA 127	
carboxylase; ACC), respectively(12). Thus, increased muscle concentrations of acetyl-128	
CoA and citrate, due to increased glycolytic flux, would increase muscle malonyl-129	
CoA concentration (via an increase in ACC activity) and, therefore, inhibit long-chain 130	
fatty acid oxidation via CPT1. In support of this theory, a significant negative 131	
correlation was obtained between muscle malonyl-CoA content and fat oxidation 132	
rates in healthy middle-aged men during a two-step euglycaemic-hyperinsulinaemic 133	
clamp(10). Furthermore, hyperglycaemia with hyperinsulinaemia increased resting 134	
skeletal muscle malonyl-CoA content 3-fold in healthy humans, resulting in a 135	
functional decrease in CPT1 activity, as evidenced by an 80% inhibition of leg 136	
[13C]oleate oxidation, with no change in [13C]octanoate oxidation(11). However, it 137	
appears that muscle malonyl-CoA concentration may not regulate long-chain fatty 138	
acid oxidation during exercise. Roepstorff et al(6) demonstrated that, despite a 122% 139	
increase in fat oxidation rates (due to depleted pre-exercise muscle glycogen content) 140	
during exercise at 65% VO2peak, there were no differences in muscle malonyl-CoA 141	
content compared to control. These findings are also supported by other human 142	
exercise studies where no association between malonyl-CoA content and fat oxidation 143	
rates were obtained in skeletal muscle during prolonged moderate-intensity 144	
exercise(13) or during graded-intensity exercise(14,15). Furthermore, a2-AMPK activity 145	
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more than doubled with an associated 6-fold increase in ACCb (muscle isoform) 146	
phosphorylation and significant decrease in malonyl-CoA concentration following 147	
both prolonged and high intensity exercise, where fat oxidation paradoxically 148	
increased and decreased, respectively(6,15). Taken together, these findings would 149	
suggest that malonyl-CoA does not play a major role in the regulation of long-chain 150	
fatty acid oxidation in human skeletal muscle during exercise.  151	
 152	
Carnitine is the principal substrate for CPT1, suggesting that it may play a role in the 153	
regulation of fat oxidation. Irving Fritz and colleagues first established that 154	
mitochondria in a variety of tissues are impermeable to fatty acyl-CoA, but not to 155	
fatty acylcarnitine, and that carnitine and CPT1 are essential for the translocation of 156	
long-chain fatty acids into skeletal muscle mitochondria for b-oxidation(16). Since 157	
these discoveries it has been established that CPT1, situated within the outer 158	
mitochondrial membrane, catalyses the reversible esterification of carnitine with long-159	
chain acyl-CoA to form long-chain acylcarnitine. Cytosolic acylcarnitine is then 160	
transported into the mitochondrial matrix in a simultaneous 1:1 exchange with 161	
intramitochondrial free carnitine via the carnitine acylcarnitine translocase (CACT), 162	
which is situated within the mitochondrial inner membrane (Figure 1). Once inside 163	
the mitochondrial matrix, acylcarnitine is transesterified back to free carnitine and 164	
long-chain acyl-CoA in a reaction catalysed by carnitine palmitoyltransferase 2 165	
(CPT2), which is situated on the matrix side of the inner mitochondrial membrane. 166	
The intramitochondrial long-chain acyl-CoA is then oxidised and cleaved by the b-167	
oxidation pathway(17). The significance of this “carnitine cycle” to fat oxidation 168	
during exercise is highlighted in patients with carnitine, CPT2, or CACT deficiency 169	
(CPT1 deficiency appears to be incompatible with life) who typically experience 170	
severely reduced rates of fat oxidation during prolonged exercise along with muscle 171	
pain and weakness, hypoglycaemia, and hypoketosis. CPT1 is considered to be the 172	
rate-limiting enzyme for long-chain fatty acid entry into the mitochondria and 173	
oxidation, but carnitine is classically not thought to be rate limiting to CPT1. Indeed, 174	
the concentration of carnitine in skeletal muscle is around 5 mM intracellular water(18) 175	
and far in excess of the in vitro Michaelis-Menten constant (Km) of muscle CPT1 for 176	
carnitine of approximately 0.5 mM(19). However, the enzymes of the carnitine cycle 177	
co-immunoprecipitate and are mainly located in the specialised contact sites between 178	
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outer- and inner-mitochondrial membranes in order to allow metabolic channelling(20). 179	
Thus, it is likely that the intramitochondrial content of free carnitine determines 180	
carnitine availability to CPT1 and, as this is around 10% of the whole muscle 181	
carnitine pool(21), that in vivo carnitine availability could be rate limiting to the CPT1 182	
reaction. Indeed, during conditions of high glycolytic flux, such as during exercise at 183	
a high intensity or with elevated carbohydrate availability, muscle free carnitine 184	
availability is reduced(2,6). 185	
 186	
Free carnitine availability is reduced during high intensity exercise 187	
The reduction in free carnitine availability observed with high glycolytic flux first 188	
became apparent in 1966 when Childress and colleagues recognised that the blowfly 189	
flight muscle, which does not oxidise fatty acids during flight, was rich in carnitine 190	
and carnitine acetyltransferase (CAT) (22). During the initial phase of flight, acetyl-191	
CoA from glycolysis was generated faster than its utilisation by the TCA cycle, with a 192	
corresponding 4-fold increase in acetylcarnitine. Childress suggested that carnitine 193	
accepted the excess acetyl groups, via the action of mitochondrial carnitine 194	
acetyltransferase, in order to maintain a viable pool of free coenzyme A to permit the 195	
continuation of pyruvate oxidation (Figure 1). Subsequent work from Harris and 196	
colleagues in humans and thoroughbred horses demonstrated that following a few 197	
minutes of intense, near maximal exercise, muscle free carnitine content was reduced 198	
from approximately 80% of the total muscle carnitine pool at rest (muscle total 199	
carnitine content is approximately 20 mmol×(kg dry muscle)-1 in humans) to around 200	
20%, with almost all of the reduction being attributed to formation of 201	
acetylcarnitine(23,24,25). However, there was no change in muscle acetylcarnitine 202	
content following a few minutes of exercise at lower intensities(26,27). Constantin-203	
Teodosiu and colleagues(28) also demonstrated a rapid increase in acetylcarnitine 204	
formation in humans from 3 to 13 mmol×(kg dm)-1 following 3 min of intense exercise 205	
at 75% VO2max. Furthermore, over the next hour of exercise, acetylcarnitine 206	
gradually increased to 16 mmol×(kg dm)-1, suggesting that exercise duration, as well 207	
as intensity, contributes to acetylcarnitine accumulation, albeit to a lesser degree. If a 208	
second bout of exercise is performed(29), or if exercise is continued for several 209	
hours(30), then acetyl-CoA availability may actually be less than the demands of the 210	
TCA cycle and the stockpiled acetyl groups can be used as a fuel source via the 211	
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reverse CAT reaction (Figure 1). Indeed, Seiler et al(31) recently observed an inability 212	
to use stockpiled acetylcarnitine following exercise in an incomplete CAT knockout 213	
mouse, i.e. the incomplete reverse CAT reaction resulted in a decline in acetyl-CoA. 214	
However, this did not warrant their conclusion “this observation is consistent with the 215	
premise that during intense exercise CAT catalyzes net flux in the direction of acetyl-216	
CoA”, which is certainly not consistent with the aforementioned studies in humans 217	
that observed a net accumulation of acetlycarnitine during intense exercise. 218	
 219	
Research by van Loon et al(2) demonstrated that a 35% decrease in the rate of long-220	
chain fatty oxidation that occurred at an exercise intensity above 70% VO2max, 221	
measured using a [U-13C]palmitate tracer, was paralleled by a 65% decrease in 222	
skeletal muscle free carnitine content. In support of these findings, Roepstorff et al(6) 223	
demonstrated a 2.5-fold decrease in the rate of fat oxidation, compared to control, 224	
during moderate intensity exercise (65% VO2max) when free carnitine availability 225	
was reduced to 50% (12 mmol×(kg dm)-1) of the total carnitine store, as a result of 226	
pyruvate, and thereby acetyl-CoA, production being increased due to elevated pre-227	
exercise muscle glycogen stores. Also, during bicycle exercise at 75% VO2max to 228	
exhaustion, both muscle free carnitine content and fat oxidation rates were markedly 229	
higher with low pre-exercise muscle glycogen content compared to control(32). Taken 230	
together, the above studies suggest a relationship between skeletal muscle free 231	
carnitine availability (and therefore carbohydrate metabolism) and the regulation of 232	
long-chain fatty acid oxidation rates, via CPT1, in human skeletal muscle during 233	
exercise.  234	
 235	
Is reduced free carnitine availability related to insulin resistance? 236	
It would be remiss not to mention a recent growing body of research in the area of 237	
skeletal muscle carnitine metabolism, particularly related to skeletal muscle insulin 238	
resistance. Insulin resistance is characterized by a ‘metabolic inflexibility’ in the 239	
reciprocal relationship between fatty acid and glucose oxidation within skeletal 240	
muscle(33). In keeping with observation in the same incomplete CAT knockout model 241	
by Muoio et al(34), a recent article of Lindboom and colleagues(35) asserts that “the 242	
transformation of excessive acetyl-CoA into acetylcarnitine is important to maintain 243	
metabolic flexibility”, and that “compromised capacity to generate acetylcarnitine, 244	
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either due to reduced CAT activity or low carnitine concentration, may reduce 245	
pyruvate dehydrogenase (PDH) activity, hence reducing oxidative degradation of 246	
glucose”. Contrary to this opinion, biochemically determined human muscle 247	
acetylcarnitine content is reduced under insulin-stimulated, high glucose 248	
conditions(36), and increased in the insulin resistant state(37,38). What’s more, as 249	
mentioned above, compelling evidence has demonstrated a positive, constant linear 250	
relationship exists between muscle acetyl-CoA formation and acetylcarnitine 251	
accumulation over low to maximum rates of mitochondrial flux(22, 24, 27, 39). 252	
Lindeboom et al(35) themselves report maximal ex vivo CAT activity in participants 253	
with type 2 diabetes (T2D) of 52.6 nmol/mg protein/min, which is far in excess of 254	
PDC flux rates even during high intensity exercise (15 nmol/mg protein/min)(27). This 255	
clearly demonstrates that CAT is not limiting the equilibrium between acetyl-CoA 256	
and acetylcarnitine, making it highly unlikely that acetylcarnitine accumulation could 257	
be compromised for reasons other than rates of acetyl-CoA formation from PDH or β-258	
oxidation reactions.  Illustrated another way, if CAT activity was indeed limiting in 259	
insulin resistant individuals, then mitochondrial ATP production would be markedly 260	
suppressed, as the rapid sequestering of the micromolar concentrations of 261	
mitochondrial free CoA as acetyl-CoA would immediately compromise PDH and 262	
TCA cycle flux. This clearly doesn’t happen, rather it’s likely that group differences 263	
in ex vivo maximal CAT activity and in vivo mitochondrial function reported by 264	
Lindboom et al(35) would be dissipated if corrected for mitochondrial content, 265	
particularly given the apparent impairment of muscle mitochondrial function in 266	
patients with T2D is accounted for by differences in mitochondrial content(40). Finally, 267	
the resting muscle acetylcarnitine content of participants with T2D in Lindboom et al. 268	
was 12% of the measured total carnitine pool, suggesting that free carnitine was 88% 269	
of the total muscle carnitine pool and making it highly improbable that free carnitine 270	
availability was limiting to PDH flux and acetylcarnitine formation. 271	
 272	
Can skeletal muscle carnitine content be increased? 273	
Further insight into whether free carnitine availability is limiting to CPT1 and the rate 274	
of fatty acid oxidation can be provided by increasing skeletal muscle carnitine 275	
content. However, the majority of the pertinent studies in healthy humans to date have 276	
failed to increase skeletal muscle carnitine content via oral or intravenous L-carnitine 277	
administration(39). For example, neither feeding L-carnitine daily for up 3 months(41), 278	
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nor intravenously infusing L-carnitine for up to 5 hours(42), had an effect on muscle 279	
total carnitine content, or indeed net uptake of carnitine across the leg(43) or arm(44) 280	
(Table 1). Furthermore, feeding 2-5 g×d-1 of L-carnitine for 1 week to 3 months prior 281	
to a bout of exercise, had no effect on perceived exertion, exercise performance, 282	
VO2max, or markers of muscle substrate metabolism such as RER, VO2, blood 283	
lactate, leg FFA turnover, and post exercise muscle glycogen content(39). What was 284	
apparent from the earlier carnitine supplementation studies was that muscle carnitine 285	
content was either not measured or, if it was, not increased. This is likely explained 286	
by the finding that carnitine is transported into skeletal muscle against a considerable 287	
concentration gradient (>100 fold) that is tightly regulated and saturated under normal 288	
conditions, and so it is unlikely that simply increasing plasma carnitine availability 289	
per se will increase muscle carnitine transport and storage(39). Indeed, recent human 290	
and porcine studies of arterio-venous carnitine fluxes confirmed that net muscle 291	
carnitine uptake/efflux is negligible under fasting conditions(44, 45), with systemic 292	
concentrations of carnitine and acylcarnitines largely governed by gut absorption, 293	
hepatic release and renal filtration(45). However, insulin appears to stimulate skeletal 294	
muscle carnitine transport, and intravenously infusing L-carnitine in the presence of 295	
high circulating insulin (>50 mU×l-1) can increase muscle carnitine content by 296	
15%(36,42, 46). Furthermore, ingesting relatively large quantities of carbohydrate in a 297	
beverage (>80 g) can stimulate insulin release to a sufficient degree to increase whole 298	
body carnitine retention when combined with 3 g of carnitine feeding and, if 299	
continued for up to 6 months (80 g carbohydrate + 1.36 g L-carnitine twice daily) can 300	
increase the muscle store by 20% compared to carbohydrate feeding alone(47). Indeed, 301	
ingesting 80 g of carbohydrate facilitated a positive net arterio-venous carnitine 302	
balance across the forearm(44) which, assuming the majority of the measured plasma 303	
carnitine extraction across the forearm occurred into skeletal muscle, equated to a 304	
whole body muscle accumulation of 390 µmol and aligned well with the 370 µmol 305	
(60 mg) carnitine retention predicted from differences in urinary carnitine excretion in 306	
previous studies(48). Extended to a chronic feeding scenario, this would equate to a 307	
daily increase in muscle carnitine content of 50 µmol×(kg dm)-1, which would 308	
augment muscle total carnitine content stores (~20 mmol×(kg dm)-1) by 22% over 12 309	
weeks. Again, this extrapolation is in good agreement with the 21% increase in 310	
muscle carnitine content reported by Stephens et al(49). However, such a large 311	
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carbohydrate load per se (160 g×d-1) will likely affect metabolism and alter body 312	
composition(49) and so investigation into alternative oral insulinogenic formulations 313	
that can stimulate muscle carnitine accumulation using lower carbohydrate loads is 314	
warranted. For example, whey protein has previously been fed with carbohydrate to 315	
promote insulin-mediated muscle creatine retention(50) and, unlike carbohydrate, 316	
prolonged protein supplementation is less likely to influence body fat content(51). 317	
Unpublished data from our lab would suggest that daily feeding of 3 g of L-carnitine 318	
in combination with a beverage containing 44 g of carbohydrate and 13 g of protein 319	
results in around a 20% increase in the muscle carnitine pool over 24 weeks (Chee et 320	
al, unpublished results). 321	
 322	
Insert Table 1 here 323	
 324	
Does increasing muscle carnitine content reduce the inhibition of fat oxidation 325	
during high intensity exercise? 326	
Consistent with the hypothesis that free carnitine availability is limiting to CPT1 flux 327	
and fat oxidation, the increase in muscle total carnitine content in the study of Wall et 328	
al(47) equated to an 80% increase in free carnitine availability during 30 minutes of 329	
exercise at 50% VO2max compared to control and resulted in a 55% reduction in 330	
muscle glycogen utilisation. Furthermore, this was accompanied by a 30% reduction 331	
in PDC activation status during exercise, suggesting that a carnitine mediated increase 332	
in fat derived acetyl-CoA inhibited PDC and muscle carbohydrate oxidation. Put 333	
another way, L-carnitine supplementation increased muscle free carnitine 334	
concentration during exercise at 50% VO2max from 4.4 to 5.9 mmol×l-1 intracellular 335	
water, equating to an intra-mitochondrial concentration of 0.44 and 0.59 mmol×l-1, 336	
which is below and above the Km of CPT1 for carnitine, respectively(19). On the other 337	
hand, during 30 min of exercise at 80% VO2max with increased muscle total carnitine 338	
content the same apparent effects on fat oxidation were not observed(47). In contrast, 339	
there was greater PDC activation (40%) and flux (16% greater acetylcarnitine), 340	
resulting in markedly reduced muscle lactate accumulation in the face of similar rates 341	
of glycogenolysis compared to control. This suggested that free carnitine availability 342	
was limiting to PDC flux during high intensity exercise and that increasing muscle 343	
carnitine content resulted in a greater acetyl-CoA buffering capacity and better 344	
	 12	
matching of glycolytic to PDC flux. The study by Wall et al(47) also demonstrated a 345	
remarkable improvement in exercise performance in all participants (11% mean 346	
increase) during a 30-minute cycle ergometer time trial in the carnitine loaded state. 347	
This is consistent with animal studies reporting a delay in fatigue development by 348	
25% during electrical stimulation in rat soleus muscle strips incubated in carnitine in 349	
vitro(52). Whether these improvements in endurance performance are due to glycogen 350	
sparing as a result of a carnitine mediated increase in fat oxidation, or the reduced 351	
reliance on non-oxidative ATP production from carbohydrate oxidation (increase 352	
acetyl group buffering and reduced lactate accumulation) requires further 353	
investigation, but due to the high intensity nature of the time trial the latter would 354	
appear more likely. Nevertheless, the long-held belief that carnitine supplementation 355	
can improve endurance performance via augmenting its role in fat oxidation should be 356	
revised to place more emphasis on the major role that carnitine plays in carbohydrate 357	
metabolism during exercise. 358	
 359	
Does increasing muscle carnitine content affect muscle metabolism during very 360	
high intensity exercise?  361	
During very high intensity exercise (>100% VO2max), where there is a negligible 362	
contribution of fat oxidation to energy expenditure, there is a plateau in muscle 363	
acetyl-group accumulation that is associated with a greatly accelerated rate of lactate 364	
production(39,53). This increasing proportion of glycolytic flux that is directed towards 365	
lactate formation is often cited as a key component in the development of fatigue 366	
during very intense exercise(54). Under these conditions it is unclear whether free 367	
carnitine availability is limiting to PDC flux and mitochondrial ATP resynthesis, or 368	
simply that TCA cycle flux and PDC flux (i.e. mitochondrial capacity) are maximal. 369	
This is most evident during repeated bouts of very high intensity exercise, where 370	
acetylcarnitine accumulation during the first bout of exercise prevents further acetyl 371	
group buffering during subsequent bouts due to reduced free carnitine availability, 372	
which results in an increased reliance on phosphocreatine degradation (indicative of a 373	
declining contribution from mitochondrial ATP delivery) and ultimately fatigue(55). 374	
Thus, if carnitine availability is indeed limiting to PDC flux during intense, repeated-375	
bout exercise, it is plausible that increasing skeletal muscle carnitine availability as 376	
in(47) during a prolonged period of high intensity interval (i.e. repeated bout) training 377	
(HIIT) could influence the adaptations to this type of training. However, we have 378	
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recently demonstrated that although increasing skeletal muscle free carnitine content 379	
via 24 weeks of twice daily L-carnitine (1.36 g) and carbohydrate (80 g) feeding 380	
increased the capacity to buffer excess acetyl groups during a single 3 min bout of 381	
high-intensity exercise at 100% VO2max (as evidenced by a reduced muscle 382	
phosphocreatine degradation), it did not further influence skeletal muscle metabolism 383	
during a repeated bout, nor improve training-induced changes in muscle metabolism, 384	
VO2max, or work output over 24 weeks of HIIT(55). This would suggest that either 385	
acetylcarnitine formation, or PDC flux, is not limiting to mitochondrial ATP delivery 386	
during repeated bouts of exercise of this duration and intensity, or that the adaptations 387	
to HIIT outweighed any benefit of increasing free carnitine availability. Indeed, 388	
following 24 weeks of HIIT non-mitochondrial ATP production and acetylcarnitine 389	
accumulation during a second bout of exercise were blunted to such an extent that 390	
they were lower than the pre-training first bout, suggesting a better matching of PDC 391	
and TCA cycle flux during repeated bouts of exercise and a lower dependence on 392	
mitochondrial acetyl-group buffering. 393	
 394	
Conclusion 395	
In conclusion, it appears that skeletal muscle carnitine availability influences fuel 396	
selection during exercise. Carnitine availability appears limiting to the CPT1 reaction, 397	
such that during high intensity exercise a carbohydrate flux mediated decline in free 398	
carnitine is paralleled by a decline in the rate of fat oxidation. Indeed, nutritionally 399	
increasing skeletal muscle carnitine content increases fat oxidation during low 400	
intensity exercise. However, increasing carnitine availability during high intensity 401	
exercise does not offset the decline in fat oxidation, but facilitates a better matching of 402	
carbohydrate flux by buffering excess acetyl groups from the PDC reaction. This, the 403	
long-held belief that carnitine supplementation can improve endurance performance 404	
via augmenting its role in fat oxidation should be revised to place more emphasis on 405	
the major role that carnitine plays in carbohydrate metabolism during exercise, 406	
particularly as increasing muscle carnitine content can improve high intensity exercise 407	
performance and most athletes compete at high exercise intensities. However, caution 408	
should be taken as nutritionally increasing carnitine content appears to have little 409	
effect during repeated bouts of exercise at very high intensities or adaptation to HIIT 410	
training, likely because oxidative metabolism is already maximal.     411	
  412	
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Tables 638	
 639	
Table 1. A summary of studies that have measured muscle carnitine content or 640	
balance following L-carnitine administration 641	
Reference Dose of L-
carnitine 
Combined 
with insulin? 
Change in 
muscle 
carnitine  
Effect on 
metabolism 
Shannon et 
al.(44) 
1 x 3 g orally No No net uptake 
across forearm 
Not measured 
Shannon et 
al.(44) 
1 x 3 g orally Ingested 1 hour 
before 80 g of 
maltodextrin 
Approx. 
0.25%/day 
increase 
across forearm 
Not measured 
Shannon et 
al.(44) 
1 x 3 g orally Ingested 1 hour 
before 40 g of 
maltodextrin + 
40 g of whey 
protein 
No net uptake 
across forearm 
Not measured 
Soop et al.(43) 1 x 5 g/day 
orally for 5 
days 
No Net release of 
carnitine from 
the leg 
No 
Stephens et 
al.(42) 
Approx. 5 g 
intravenously 
over 5 hours 
6 hours 
intravenous 
infusion of 
insulin to 
achieve fasting 
(5 mU/l) serum 
insulin 
concentration 
No change in 
vastus 
lateralis total 
carnitine 
content 
No 
Stephens et 
al.(42) 
Approx. 5 g 
intravenously 
over 5 hours 
6 hours 
intravenous 
infusion of 
insulin to 
13% increase 
in vastus 
lateralis total 
carnitine 
Not measured 
	 23	
achieve 180 
mU/l serum 
insulin 
concentration 
content 
Stephens et 
al.(46) 
Approx. 5 g 
intravenously 
over 5 hours 
6 hours 
intravenous 
infusion of 
insulin to 
achieve >50 
mU/l serum 
insulin 
concentration 
10% increase 
in whole body 
plasma 
carnitine 
clearance vs. 5 
mU/l serum 
insulin 
Not measured 
Stephens et 
al.(36) 
Approx. 5 g 
intravenously 
over 5 hours 
6 hours 
intravenous 
infusion of 
insulin to 
achieve 180 
mU/l serum 
insulin 
concentration 
15% increase 
in vastus 
lateralis total 
carnitine 
content 
Inhibition of 
PDC and 
diversion of 
carbohydrate 
flux to storage 
as glycogen  
Wächter et 
al.(41) 
2 x 2 g/day 
orally for 3 
months 
No No change in 
vastus 
lateralis total 
carnitine 
content 
No 
Stephens et 
al.(49) 
2 x 1.36 g/day 
orally for 12 
weeks 
Ingested with 
80 g of high 
molecular 
weight glucose 
polymer 
20% increase 
in vastus 
lateralis total 
carnitine 
content 
Increase in 
energy 
expenditure at 
50% VO2max. 
Wall et al.(47) 
 
2 x 1.36 g/day 
orally for 24 
weeks 
Ingested with 
80 g of high 
molecular 
20% increase 
in vastus 
lateralis total 
Sparing of 
muscle 
glycogen at 
	 24	
weight glucose 
polymer 
carnitine 
content 
50% VO2max. 
Better 
matching of 
carbohydrate 
to TCA cycle 
flux at 80% 
VO2max. 
Increase in 
cycling time 
trial 
performance.  
Shannon et 
al.(55)  
2 x 1.36 g/day 
orally for 24 
weeks in 
combination 
with HIIT 
training 
Ingested with 
80 g of 
maltodextrin 
30% increase 
in vastus 
lateralis free 
carnitine 
content vs. 
placebo 
Increase in 
efficiency at 
VO2max. No 
adaptation to 
HIIT training. 
Chee et al. 
unpublished.  
1 x 3 g/day 
orally for 25 
weeks 
Ingested with 
nutritional 
supplement 
containing 44 g 
of maltodextrin 
and 13 g of 
whey protein 
20% increase 
in vastus 
lateralis total 
carnitine 
content 
20% increase 
in fat oxidation 
at 50% 
VO2max. 
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Figures and Legends 643	
 644	
Figure 1. A schematic diagram of the roles of carnitine within the context of skeletal 645	
muscle fuel metabolism for ATP resynthesis during exercise. Carnitine’s role in long-646	
chain fatty acid (acyl group) translocation into the mitochondrial matrix, for 647	
subsequent b-oxidation is highlighted in red, whereas the role of carnitine as a buffer 648	
of excess acetyl-CoA production and as a stockpile of acetyl groups is highlighted in 649	
blue. PDC, pyruvate dehydrogenase complex; TCA, tricarboxylic acid cycle; CAT, 650	
carnitine acetyltransferase; CACT, carnitine acylcarnitine translocase; CPT, carnitine 651	
palmitoyltransferase. 652	
